COX-2/sEH Dual Inhibitor PTUPB Suppresses Glioblastoma Growth by Targeting Epidermal Growth Factor Receptor and Hyaluronan Mediated Motility Receptor

Oncotarget - United States
doi 10.18632/oncotarget.20928
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma

PLoS ONE
Multidisciplinary
2016English

Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer

Cancer Control
MedicineOncologyHematology
2013English

TAS6417, a Novel Epidermal Growth Factor Receptor Inhibitor Targeting Exon 20 Insertion Mutations

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Hyaluronan-Mediated Motility Receptor (RHAMM; CD168)

Science-Business eXchange
2014English

Epidermal Growth Factor Receptor Inhibitor Therapy for Recurrent Respiratory Papillomatosis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2013English

Nursing Management of Epidermal Growth Factor Receptor Inhibitor-Induced Toxicities

Clinical Journal of Oncology Nursing
Oncology
2008English

Epidermal Growth Factor Receptor Transactivation Is Required for Proteinase-Activated Receptor-2-Induced COX-2 Expression in Intestinal Epithelial Cells

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2012English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy